HIF1A and cancer: Clinical as well as basic research has shown that HIF-1 is associated with angiogenesis, metabolic reprogramming, and the invasion and metastasis of cancer cells as well as the poor prognoses of cancer patients [15, 16], which justifies the targeting of HIF-1 itself or its upstream activators for cancer therapy [15, 23].